JP2001513497A5 - - Google Patents

Download PDF

Info

Publication number
JP2001513497A5
JP2001513497A5 JP2000506954A JP2000506954A JP2001513497A5 JP 2001513497 A5 JP2001513497 A5 JP 2001513497A5 JP 2000506954 A JP2000506954 A JP 2000506954A JP 2000506954 A JP2000506954 A JP 2000506954A JP 2001513497 A5 JP2001513497 A5 JP 2001513497A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000506954A
Other versions
JP2001513497A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IT1997/000209 external-priority patent/WO1999007363A1/en
Publication of JP2001513497A publication Critical patent/JP2001513497A/ja
Publication of JP2001513497A5 publication Critical patent/JP2001513497A5/ja
Pending legal-status Critical Current

Links

JP2000506954A 1997-08-08 1997-08-08 胃分泌過多および腎損傷の予防作用を有する抗炎症剤の製造のための化合物2−メトキシフェニル−1−メチル−5p−メチルベンゾイル−ピロール−2−アセトアミドアセテートの使用 Pending JP2001513497A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT1997/000209 WO1999007363A1 (en) 1997-08-08 1997-08-08 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment

Publications (2)

Publication Number Publication Date
JP2001513497A JP2001513497A (ja) 2001-09-04
JP2001513497A5 true JP2001513497A5 (ja) 2005-11-17

Family

ID=11332729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000506954A Pending JP2001513497A (ja) 1997-08-08 1997-08-08 胃分泌過多および腎損傷の予防作用を有する抗炎症剤の製造のための化合物2−メトキシフェニル−1−メチル−5p−メチルベンゾイル−ピロール−2−アセトアミドアセテートの使用

Country Status (6)

Country Link
EP (1) EP1024807B1 (ja)
JP (1) JP2001513497A (ja)
AT (1) ATE237326T1 (ja)
DE (1) DE69721077T2 (ja)
DK (1) DK1024807T3 (ja)
WO (1) WO1999007363A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1297140B1 (it) 1997-12-24 1999-08-03 Sigma Tau Ind Farmaceuti Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e
IT1302898B1 (it) * 1998-12-03 2000-10-10 Medosan Ricerca Srl Uso di amtolmetine guacil per la produzione di farmaci ad effettoantiinfiammatorio nelle infiammazioni intestinali.
WO2004075916A1 (en) * 2003-02-27 2004-09-10 Shirankai Kyoto University Faculty Of Medicine Alumni Association Inc. Pharmaceutical composition for treatment of drug dependence
CN100390144C (zh) * 2006-03-29 2008-05-28 安徽省庆云医药化工有限公司 1-甲基-5-对甲苯酰吡咯-2-乙酰氨基乙酸愈创木酚酯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1162856A (en) * 1981-07-20 1984-02-28 Dushan M. Dvornik Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5- methoxy-2-methyl-1h-indole-3-acetic acid
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.

Similar Documents

Publication Publication Date Title
CH0944937H2 (ja)
ITCA970029A3 (ja)
ITMI971227A0 (ja)
BR9700653A (ja)
BR9701757A (ja)
BY4238C1 (ja)
BY4349C1 (ja)
CN3053170S (ja)
CN3053500S (ja)
CN3054099S (ja)
CN3054162S (ja)
CN3054556S (ja)
CN3054902S (ja)
CN3055123S (ja)
CN3055179S (ja)
CN3055389S (ja)
CN3055471S (ja)
CN3055519S (ja)
CN3055603S (ja)
CN3055713S (ja)
CN3056209S (ja)
CN3056251S (ja)
CN3056276S (ja)
CN3056417S (ja)
CN3056418S (ja)